|Previous Section||Index||Home Page|
James Brokenshire: To ask the Secretary of State for Health how many people aged (a) under 16 and (b) between 16 and 18 years were admitted to hospital with a primary or secondary diagnosis of poisoning by drugs in each of the last five years. 
Gillian Merron: The information requested is in the following table. The system of diagnostic codes used to classify admission to hospital does not distinguish between recreational, illicit misuse or medical use of drugs.
|15 years and under||16-18 years|
Hospital Episode Statistics (HES), The NHS Information Centre for health and social care
T36-Poisoning by systemic antibiotics
T37-Poisoning by other systemic anti-infectives and antiparasitics
T38-Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
T39-Poisoning by nonopioid analgesics, antipyretics and antirheumatics
T40-Poisoning by narcotics and psychodysleptics (hallucinogens)
T41-Poisoning by anaesthetics and therapeutic gases
T42-Poisoning by antiepileptic, sedative-hypnotic and antiparkinsonism drugs
T43-Poisoning by psychotropic drugs, not elsewhere classified
T44-Poisoning by drugs primarily affecting the autonomic nervous system
T45-Poisoning by primarily systemic and haematological agents, not elsewhere classified
T46-Poisoning by agents primarily affecting the cardiovascular system
T47-Poisoning by agents primarily affecting the gastrointestinal system
T48-Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
T49Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolaryngological and dental drugs
T50-Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
James Brokenshire: To ask the Secretary of State for Health how many people entering treatment with the National Treatment Agency for Substance Misuse left treatment free of their drug dependency (a) with no drug use and (b) with occasional drug use in each year since such information started to be counted within the National Drug Treatment Monitoring System. 
Gillian Merron: The National Treatment Agency for Substance Misuse does not provide drug treatment but assures the delivery of local drug treatment services and collects data about treatment via the National Drug Treatment Monitoring System.
|Trends in treatment exit reasons (clients aged 18 or over)|
Statistics for 2008-09 were collected using a new methodology. The data for previous years presented above have been modified to fit the new methodology and excludes under 18-year olds to enable comparisons to be made.
"No drug use" means that in the opinion of the treating clinician, the client is not only free of dependency but is not using any other illicit drugs at all on exiting treatment. Others successfully completing treatment may acknowledge occasional use of other illicit drugs which are judged by the clinician not to require treating.
For figures under the previous methodology, including under 18-year olds, for the years 2004-05 to 2007-08 I refer the hon. Member to the written answer I gave him on 9 July 2009, Official Report, column 974W.
Gillian Merron: So far the Department has spent approximately £500,000 in the development of the Let's Get Moving tools including the commissioning guidance on physical activity care pathway - Let's Get Moving. We are planning delivery and roll out activities over the coming months.
Gillian Merron: As set out in "Be Active, Be Healthy - A plan for getting the nation moving" the Fit for the Future pilot which commenced in April 2009 is running for 12 months in targeted areas in five local authorities (Suffolk, Manchester, Torbay, Bristol and Newcastle). A copy of the plan has already been placed in the Library.
Any future funding and delivery arrangements for Fit for the Future will be subject to the outcome of the monitoring and evaluation that has been put in place. A final report on the programme is due in June 2010.
Bill Wiggin: To ask the Secretary of State for Health how many impact assessments conducted by the Food Standards Agency as part of its written consultations included rural-proofing analyses (a) before and (b) after 19 May 2009. 
Gillian Merron: A rural proofing analysis has been included in six of the Food Standards Agency's consultation stage impact assessments for England published before 19 May 2009, and two after 19 May 2009.
Mr. Meacher: To ask the Secretary of State for Health what the (a) objectives and (b) terms of reference are of the programme of consumer engagement on genetic modification which he has asked the Food Standards Agency (FSA) to undertake; and what budget has been allocated for the project by (i) his Department and (ii) the FSA. 
Gillian Merron: This work, which will explore public awareness, knowledge and attitudes about genetically modified foods, is at the initial stages of development, and a budget has still to be finalised. It will be funded by the Food Standards Agency and other Departments with an interest, with co-funding from Sciencewise. The programme will be overseen by an independent steering group that will agree terms of reference when it meets for the first time on 25 and 26 November 2009.
Mr. Meacher: To ask the Secretary of State for Health which research projects have been funded by (a) his Department and its predecessors and (b) the Biotechnology and Biological Sciences Research Council on the safety of genetically modified food in the last 10 years. 
Gillian Merron: Since April 2000, the Food Standards Agency (FSA) has commissioned work under three research programmes relevant to the safety of genetically modified (GM) foods. Prior to April 2000, food safety research was the responsibility of the Ministry of Agriculture, Fisheries and Food (MAFF). Details of the individual projects commissioned by MAFF and the FSA are available on the research pages of the Food Standards Agency's website at:
The Biotechnology and Biological Sciences Research Council has not funded any research during the last 10 years specifically on the safety of genetically modified food, but it has funded one project to analyse gene transfer from food plants to human intestinal microflora and intestinal epithelium.
Mr. Charles Kennedy: To ask the Secretary of State for Health pursuant to the answer of 14 October 2009, Official Report, column 900W, on haemophilia, to which viruses haemophiliacs have been exposed through infected blood products in the last 10 years; how many cases of each (a) viral infection and (b) combination of viral infections have been reported to his Department; and what estimate he has made of the number of such cases unreported in the last 10 years. 
Gillian Merron: The Medicines and Healthcare products Regulatory Agency's (MHRA's) Yellow Card reporting system is used by health care professionals and patients to voluntarily report suspected adverse reactions to medicines. Those reported reactions involving fractionated blood products, which may be related to quality issues are recorded on the MHRA's Defects database.
MHRA officials have searched this database for cases of viral infection resulting from contamination of fractionated blood products over the past 10 years. There are no confirmed reports of viral transmission through contaminated blood products on the database for this period.
Blood products manufactured from fractionated pools of donated plasma, such as clotting factors, are highly
regulated in accordance with the European Community code for medicinal products as defined in Directive 2001/83/EC as amended. This means that the possibility of virus transmission through blood products is likely now to be rare, but it is not possible to completely eliminate infection risk. One case of variant Cretzfeldt-Jakob disease infection in a haemophilia patient was reported in February 2009. The origin of this non-viral infection is uncertain, but it is likely to have been via blood products during the 1990s.
Norman Lamb: To ask the Secretary of State for Health what procedures his Department used to take account of scientific evidence in taking decisions on which health promotion campaigns to undertake or commission in (a) 2005-06, (b) 2006-07, (c) 2007-08 and (d) 2008-09. 
Gillian Merron: The Department takes scientific evidence into account when making policy decisions including undertaking or commissioning health promotion campaigns. For example, the National Institute for Health and Clinical Excellence have produced guidance that can be used as the basis for planning, delivering and evaluating public health activities aimed at changing health-related behaviours. The guidance is for national health service and non-NHS professionals and others including national policy makers in health and related sectors.
Norman Lamb: To ask the Secretary of State for Health how much his Department has spent on (a) consultants, (b) advertising, (c) publishing, (d) public relations, (e) professional training and (f) other activities for each health promotion campaign (i) run by the Department and (ii) commissioned from other organisations, in (A) 2005-06, (B) 2006-07, (C) 2007-08 and (D) 2008-09; and which organisation ran each campaign which was not run by the Department. 
|Department of Health advertising spend in 2005-06 to 2008-09( 1)|
|(1) Advertising spend is defined as covering only media spend (inclusive of agency commissions but excluding production costs, COI commission and VAT). All figures exclude advertising rebates and audit adjustments and therefore may differ from COI official turnover figures. All figures are rounded to the nearest £10,000. These figures do not include departmental recruitment/classified advertising costs and ad hoc spend under £10,000. These figures may include occasional minor spend through COI by NHS organisations, to supplement national campaigns in their area. While this expenditure has been excluded as far as possible so that this chart reflects central departmental spend, it would incur disproportionate cost to validate that every item of NHS expenditure has been removed.|
|Next Section||Index||Home Page|